Epoprostenol for Injection in Patients With Pulmonary Arterial Hypertension

Summary

This is an open-label, nonrandomized extension to study AC-066A301. The study will assess safety and tolerability of ACT-385781A while providing a means for continuing treatment after ending participation in study AC-066A301.

Timeline

Start

2011-06-01

Primary completion

2015-06-01

Completion

2015-07-01

Drugs

Indications